Health Care Equity Cannot Afford Further Delays Health Care Equity Cannot Afford Further Delays
In this commentary, the author makes the case for universal health care coverage and equitable reimbursement across payers to insure equitable health care across all demographics.JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Can Kawasaki Disease Cause Heart Failure?
Title: Can Kawasaki Disease Cause Heart Failure?Category: Diseases and ConditionsCreated: 12/1/2021 12:00:00 AMLast Editorial Review: 12/1/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - December 1, 2021 Category: Cardiology Source Type: news

Atrium Health Sanger Heart & Vascular Institute treats heart failure patients using new therapy
Under the care of Dr. Brian Powell at Atrium Health Sanger Heart& Vascular Institute, James Rorie was the first patient in the Charlotte region to receive a newly approved FDA therapy to treat heart failure, called Cardiac Contractility Modulation (CCM). Hear Rorie ’s story and how this new therapy improves quality of life for patients like him struggling with heart failure. Learn more about CCM therapy at Sanger Heart& Vascular Institute. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 1, 2021 Category: Pharmaceuticals Authors: Atrium Health Source Type: news

Insomnia, a New Modifiable Risk Factor for Heart Failure? Insomnia, a New Modifiable Risk Factor for Heart Failure?
A new study investigates the association between chronic insomnia and incident heart failure. Might treatment of insomnia symptoms reduce cardiovascular risk and HF incidence?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Acute heart failure due to aluminum phosphide poisoning - Petrovic M, Otero D, Leigh A, Singh V.
We present a case of severe reversible cardiomyopathy and left ventricular apical thrombus in a patient who worked as an exterminator and had ALP poisoning. ... (Source: SafetyLit)
Source: SafetyLit - November 29, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Approach to Weaning Temporary Mechanical Circulatory Support Approach to Weaning Temporary Mechanical Circulatory Support
When should percutaneous temporary mechanical circulatory support be used in patients with cardiogenic shock, and what is the optimal approach to device weaning or explant?JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Daily Aspirin Linked to Increased Risk of Heart Failure Daily Aspirin Linked to Increased Risk of Heart Failure
New data from a follow-up of more than 30,000 participants without heart failure at enrollment suggests that daily use of aspirin is associated with new onset heart failure.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 24, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Researchers discover an unexpected regulator of heart repair
FINDINGSA study using mice by scientists atthe  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA reveals that cardiac muscle cells play a pivotal role in determining how the heart heals following a heart attack.  The findings challenge a longstanding paradigm about heart repair and identify a protein that could serve as a target for drugs to treat or prevent heart failure.BACKGROUNDHeart attack is the leading cause of heart failure, which kills more than 600,000 people in the U.S. each year.  An optimal repair response is critical for minimizing the amount of scarring after...
Source: UCLA Newsroom: Health Sciences - November 23, 2021 Category: Universities & Medical Training Source Type: news

Aspirin is linked with increased risk of heart failure
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC). Predisposing factors included smoking, obesity, high blood pressure, high cholesterol, diabetes, and cardiovascular disease. (Source: World Pharma News)
Source: World Pharma News - November 23, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Boehringer Ingelheim's diabetes pill Jardiance gets CDSCO nod for use against heart failure
German drug maker Boehringer Ingelheim has won approval from the Indian drug regulator to market its top-selling type-2 diabetes medication Jardiance (empagliflozin) in India, for additional indication to reduce the risk of heart failure in adults. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 22, 2021 Category: Pharmaceuticals Source Type: news

Stem Cell Therapy Boosts Outcomes for Some Heart Failure Patients
Title: Stem Cell Therapy Boosts Outcomes for Some Heart Failure PatientsCategory: Health NewsCreated: 11/16/2021 12:00:00 AMLast Editorial Review: 11/17/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 17, 2021 Category: Cardiology Source Type: news

Negative Stem Cell Results in HF May Still Have Promise: DREAM-HF Negative Stem Cell Results in HF May Still Have Promise: DREAM-HF
Results of a sham-controlled trial showed no benefit on the primary endpoint of recurrent heart failure events, but major adverse cardiovascular events were nevertheless lower among treated patients.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 16, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Empagliflozin Wins in Tough Stabilized Acute-HF Setting Empagliflozin Wins in Tough Stabilized Acute-HF Setting
Early in-hospital initiation of SGLT2 inhibitors'should be considered the new standard of care'in most patients with heart failure regardless of their ejection fraction, says an expert observer.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 16, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

EHR Alerts Have No Impact on Inpatient HF Treatment or Outcomes EHR Alerts Have No Impact on Inpatient HF Treatment or Outcomes
Researchers found no signal that EHR prognostic alerts flagging 12-month mortality risk had any impact on clinical decision-making or on heart failure outcomes, in the randomized REVEAL-HF trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 16, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Finerenone, Sotagliflozin Benefit HF Despite Renal Dysfunction Finerenone, Sotagliflozin Benefit HF Despite Renal Dysfunction
New analyses from clinical trials of these cardiorenal agents showed consistent heart failure benefit across the broad spectrum of renal function, including severe dysfunction.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Why Are So Few Seniors Getting Heart Failure Rehab?
Title: Why Are So Few Seniors Getting Heart Failure Rehab?Category: Health NewsCreated: 11/9/2021 12:00:00 AMLast Editorial Review: 11/9/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 9, 2021 Category: Cardiology Source Type: news

emperor-preserved-kidney-subanalysis
Empagliflozin shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40 percent regardless of chronic kidney disease statusIn a new sub-analysis of the landmark EMPEROR-Preserved ®Phase III trial, empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure and slowed kidney function decline1 Empagliflozin consistently improved outcomes across the full range of kidney function down to an eGFR of 20 mL/min/1.73 m21 (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 5, 2021 Category: Research Source Type: news

Brigham Receives AHA Get With The Guidelines-Heart Failure Gold Plus Quality Achievement Award
Brigham and Women ’s Hospital was awarded the American Heart Association’s 2021 Get With The Guidelines-Heart Failure Gold Plus Quality Achievement Award. This award honors hospitals that demonstrate a commitment to providing heart failure patients wi (Source: BWH News)
Source: BWH News - November 3, 2021 Category: Hospital Management Source Type: news

Prefrailty, Physical Function, and Risk of Incident HF Prefrailty, Physical Function, and Risk of Incident HF
Are prefrailty and impairment of physical function, as assessed by Short Performance Physical Battery score, associated with a higher risk of incident heart failure in older adults?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2021 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Cardiovascular Disease in Pregnancy
Cardiovascular disease remains a major contributor to rising maternal morbidity and mortality. Both the pregnant woman and fetus are exposed to many potential complications as a result of the physiologic changes of pregnancy. These changes can exacerbate existing cardiac disease, as well as lead to the development of de novo issues during gestation, delivery, and the postnatal period. For women with preexisting cardiac disease, including congenital malformations, valvular disease, coronary artery disease, and aortopathies, it is crucial that they receive multidisciplinary evaluation, counseling, and optimization before con...
Source: NeoReviews recent issues - November 1, 2021 Category: Pediatrics Source Type: news

Jury Awards $6.46M in Wrongful Death Case Against Cardiologist Jury Awards $6.46M in Wrongful Death Case Against Cardiologist
Jurors in a medical malpractice case concluded that the cardiologist and his practice were negligent in the death of a 39-year-old woman with heart failure.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 29, 2021 Category: Intensive Care Tags: Cardiology News Source Type: news

Which Patients With Type 2 Diabetes Need SGLT2 Inhibitors? Which Patients With Type 2 Diabetes Need SGLT2 Inhibitors?
With an essential role established for SGLT2 inhibitors for patients with progressive renal dysfunction or heart failure, researchers discuss how best to use these agents in those with type 2 diabetes.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - October 28, 2021 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately t...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Obesity and Cardiovascular Health: The Size of the Problem Obesity and Cardiovascular Health: The Size of the Problem
An umbrella review on the topic of obesity and fatal and incident cardiovascular outcomes reveals that rising BMI is a risk factor for both coronary heart disease and heart failure.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

What is Refeeding Syndrome?
Discussion Anorexia nervosa is an eating disorder with an intense fear of being overweight (i.e. distorted body image), and self-starvation and excessive weight loss. It is more common in women (1.2%) than men (0.2%) but can be seen in both genders. Risk factors include high-intelligence, perfectionism/inflexibility, anxiety, activities where thinner body types are expected (e.g. dancer, diver, gymnast, long-distance runner, volleyball player, etc.) Other eating disorders include bulimia nervosa (i.e. cycles of binge eating and then purging), binge eating disorder (i.e. purging), orthorexia (i.e. obsessions with healthful ...
Source: PediatricEducation.org - October 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Air and Noise Pollution Linked to Increased Heart Failure Air and Noise Pollution Linked to Increased Heart Failure
Exposure to air pollution and road traffic noise over several years may increase the risk of heart failure, according to new research from a large observational study.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Air and Noise Pollution Linked to Increased Heart Failure
New observational data suggests that exposure to air pollution and road traffic noise is associated with an increased risk for new heart failure. (Source: WebMD Health)
Source: WebMD Health - October 22, 2021 Category: Consumer Health News Source Type: news

AHA News: Runner in'Optimal Health' Diagnosed With Heart Failure at 41
Title: AHA News: Runner in'Optimal Health'Diagnosed With Heart Failure at 41Category: Health NewsCreated: 10/21/2021 12:00:00 AMLast Editorial Review: 10/22/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 22, 2021 Category: Cardiology Source Type: news

Obesity in Patients with Heart Failure and LV Assist Devices Obesity in Patients with Heart Failure and LV Assist Devices
A look at best management strategies for patients with this condition.ACC.org (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - October 20, 2021 Category: Transplant Surgery Tags: Cardiology Article Source Type: news

Ghana: Covid-19 and Breast Cancer
[Ghanaian Times] A fall-out on the COVID-19 pandemic is the impact on health care on persons with chronic and non-communicable diseases. Persons with hypertension, heart failure, diabetes, asthma, and cancer are regarded as the most vulnerable to COVID-19. Persons with such diseases are most likely to suffer the complications of COVID-19. The presence of these diseases makes COVID-19 worse. Infection with COVID-19 also makes these diseases worse. Yet these vulnerable persons are reluctant to go for scheduled reviews becaus (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 20, 2021 Category: African Health Source Type: news

Injectable Patch Shows Promise for Heart Attack Recovery Injectable Patch Shows Promise for Heart Attack Recovery
An experimental patch works to restore function to damaged areas of the heart, which could ward off irregular heartbeats and heart failure.WebMD Health News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 19, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Injectable Patch Shows Promise for Heart Attack Recovery
An experimental patch works to restore function to damaged areas of the heart, which could ward off irregular heartbeats and heart failure. (Source: WebMD Health)
Source: WebMD Health - October 18, 2021 Category: Consumer Health News Source Type: news

SPECT scans identify high-risk heart failure patients
SPECT scans of patients hospitalized for heart failure can help predict thei...Read more on AuntMinnie.comRelated Reading: GE rolls out MyoSPECT cardiac nuclear medicine scanner Cardiac PET predicts outcomes in aortic stenosis Deep-learning algorithm spots carotid calcium on CT exams Could cardiac MRI screen for heart disease? PET/CT shows link between stress and fatal heart condition (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 18, 2021 Category: Radiology Source Type: news

What Causes Irritability?
Discussion Child abuse or non-accidental trauma is a clinical diagnosis. It is the constellation of history, physical examination, radiographic evaluation, laboratory testing and investigation that determines if child abuse has occurred. Irritability caused by fractures or other trauma can be a presenting symptom of abuse. Fractures can be a presentation but they are also common problems not associated with abuse. Femoral shaft fractures are estimated to account for only 1.6% of all fractures in children, therefore they are potentially more suspicious for child abuse. A review of femur fractures can be found here. A review...
Source: PediatricEducation.org - October 18, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

High blood pressure: The 'simple trick' to lower your blood pressure - 'next to no effort'
HIGH blood pressure, also called hypertension, increases your risk of having a heart attack and stroke. It can also cause kidney failure, heart failure, problems with your sight and vascular dementia. Therefore, it should not be ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - October 17, 2021 Category: Consumer Health News Source Type: news

OPSYNVI ® (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)
Toronto, ON, (October 15, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada approved OPSYNVI® (macitentan 10mg and tadalafil 40mg) for the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) to reduce morbidity in patients of WHO functional class (FC) II or III whose PAH is idiopathic, heritable, or associated with connective tissue disease or congenital heart disease.OPSYNVI® should be used in patients who are currently treated concomitantly with stable doses of macitentan 10mg and tadalafil 40mg (20mg x ...
Source: Johnson and Johnson - October 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with ...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

How one health system is using radiation to treat heart patients who ’ve run out of options
Ventricular tachycardia (VT) is a common, potentially life-threatening heart arrhythmia that occurs in the organ ’s lower chambers in patients with heart disease or heart failure, which can lead to sudden cardiac death. While there are a variety of treatments, not all of them work for people suffering from the disorder. One of the most common treatments, a cardiac catheter ablation, can fail nearly half of the time in preventing further episodes of VT. Medication is another option, but sometimes… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 12, 2021 Category: Biotechnology Authors: Laura Newpoff Source Type: news

Air and Noise Pollution May Make You Vulnerable to Heart Failure
Title: Air and Noise Pollution May Make You Vulnerable to Heart FailureCategory: Health NewsCreated: 10/8/2021 12:00:00 AMLast Editorial Review: 10/8/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 8, 2021 Category: Cardiology Source Type: news

Differential Mechanisms in HFrEF and HFpEF in Diabetes Differential Mechanisms in HFrEF and HFpEF in Diabetes
This review explores the pathophysiological mechanisms of heart failure in patients with diabetes, how they differ in patients with HFrEF vs. HFpEF, and the use of SGLT2 inhibitors in these patients.JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 8, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

COVID-19 survivors who weren't hospitalized have a 40% increased chance of heart failure
Researchers from Washington University St Louis found that even people that do not require hospitalization due to Covid are at an increased risk of complications over the next year. (Source: the Mail online | Health)
Source: the Mail online | Health - October 7, 2021 Category: Consumer Health News Source Type: news

New Data Spotlight Safety of HF Telehealth Visits in the Pandemic New Data Spotlight Safety of HF Telehealth Visits in the Pandemic
Use of a telehealth model in patients with heart failure (HF) facilitated continuity of care without increases in subsequent hospital encounters or mortality, a new study shows.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 7, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

3 years of city living raises risk of heart failure by 43%, due to noise and air pollution, study
A study on women in Denmark found those exposed to high levels of air and noise pollution increased their risk of heart failure by up to 43 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - October 7, 2021 Category: Consumer Health News Source Type: news

Air Pollution, Road Traffic Noise Exposure May Be Linked to Heart Failure
Female nurses exposed to high levels of PM2.5, NO2, and road traffic noise had enhanced risk for heart failure; risks greater in those with hypertension or former smoking history (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 6, 2021 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Internal Medicine, Pathology, Pulmonology, Journal, Source Type: news

Kidney Function and Outcomes in Patients Hospitalized With HF Kidney Function and Outcomes in Patients Hospitalized With HF
This study sought to characterize differences in quality of care and outcomes in patients hospitalized for heart failure by degree of kidney dysfunction.Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

AHA News: More Than a Decade of Intermittent Symptoms, Then Heart Failure
Title: AHA News: More Than a Decade of Intermittent Symptoms, Then Heart FailureCategory: Health NewsCreated: 10/1/2021 12:00:00 AMLast Editorial Review: 10/4/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 4, 2021 Category: Cardiology Source Type: news

Reducing Subclinical Myocardial Injury Associated HF in Blacks Reducing Subclinical Myocardial Injury Associated HF in Blacks
A new study contributes important findings on the morbid complications of physical inactivity, obesity, and HFpEF in the African American population.JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 1, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

AHA News: Severe Mental Health Disorders May Increase Risk of Death in Men With Heart Failure
Title: AHA News: Severe Mental Health Disorders May Increase Risk of Death in Men With Heart FailureCategory: Health NewsCreated: 9/30/2021 12:00:00 AMLast Editorial Review: 10/1/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 1, 2021 Category: Cardiology Source Type: news

FDA approves drug to reduce risk of serious kidney and heart complications in adults with chronic kidney disease associated with type 2 diabetes
FDA has approved Kerendia (finerenone) tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal hearts attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 30, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ejection Fraction for Guiding HF Therapy: Forget About It? Ejection Fraction for Guiding HF Therapy: Forget About It?
Is the ejection fraction on the way out as a way to direct medical therapy in patients with heart failure? Emotions are said to be high on both sides of the question.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 29, 2021 Category: Cardiology Tags: Cardiology News Source Type: news